Start with its own history
At 11.89×, H02.SI is 24.5% below its 10-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.

Current valuation, historical context, and peer comparisons.
Current P/E ratio
11.89×
24.5% belowthe 10-year annual average
Price and EPS in quote currency. Calculation details
Investors are paying 11.89 for every 1 of reported earnings per share.
Annual period-end data · 25 observations
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2025 | 13.07× | +20.7% |
| Dec 31, 2024 | 10.83× | +7.5% |
| Dec 31, 2023 | 10.07× | -29.6% |
| Dec 31, 2022 | 14.30× | -37.0% |
| Dec 31, 2021 | 22.70× | +14.6% |
| Dec 31, 2020 | 19.81× | +27.0% |
| Dec 31, 2019 | 15.60× | +5.1% |
| Dec 31, 2018 | 14.84× | -27.1% |
| Period end | P/E | Change |
|---|---|---|
| Dec 31, 2017 | 20.36× | +27.7% |
| Dec 31, 2016 | 15.95× | +62.0% |
| Dec 31, 2015 | 9.85× | -37.6% |
| Dec 31, 2014 | 15.78× | -4.4% |
| Dec 31, 2013 | 16.51× | +48.6% |
| Dec 31, 2012 | 11.11× | -14.2% |
| Dec 31, 2011 | 12.95× | +20.9% |
| Dec 31, 2010 | 10.71× | -47.3% |
| Dec 31, 2009 | 20.31× | +121.5% |
| Dec 31, 2008 | 9.17× | +0.7% |
| Dec 31, 2007 | 9.10× | -33.7% |
| Dec 31, 2006 | 13.72× | +5.6% |
| Dec 31, 2005 | 13.00× | -11.1% |
| Dec 31, 2004 | 14.62× | -20.6% |
| Dec 31, 2003 | 18.41× | -49.7% |
| Dec 31, 2002 | 36.59× | +48.7% |
| Dec 31, 2001 | 24.60× | N/M |
Change is relative to the preceding observation. N/M values are excluded from averages.
Company P/E vs. peer trailing-12-month ratios
| Company | P/E ratio |
|---|---|
H02.SI This stockHaw Par Corporation Limited | 11.89× |
42C.SIiX Biopharma Ltd. | N/M |
Peers are selected by the data provider. Business models and earnings definitions can differ.
Put the numbers in context
At 11.89×, H02.SI is 24.5% below its 10-observation annual average. A lower multiple can reflect a lower price, higher earnings, or weaker growth expectations—not necessarily a bargain.
Peer ratios add context to the company's own history. Check growth, margins, debt, and earnings quality before interpreting the gap. A faster-growing business may justify a higher multiple.
One-off gains can temporarily lower P/E; unusual charges can raise it. Reported earnings and forward estimates answer different questions. Pair this view with return on equity and liquidity for a fuller picture.
Keep your research connected
Pull historical P/E into Excel or Google Sheets with Wisesheets. Build your own comparisons alongside the rest of your financial model.
Explore Wisesheets=WISE("H02.SI", "PE Ratio", "LQ")Share price 12.37 ÷ EPS 1.04 = 11.89×. Data is supplied by Financial Modeling Prep through Wisesheets. Quote feed updated Nov 17, 2026; this is not a real-time trading quote.
Annual and quarterly P/E observations are provided separately from the current quote. Averages use the latest 3, 5, or 10 annual observations, excluding missing and nonpositive ratios. Pre-IPO observations are omitted. These are period-end observations, not daily averages.
The current quote feed does not specify the exact EPS filing-period end or whether EPS is basic or diluted. We do not label it as forward P/E. Peer ratios are explicitly trailing-12-month (TTM) values. Historical observations do not include independently verified price and EPS inputs. Sources may update on different schedules; rounded inputs can produce small calculation differences. Historical comparisons describe past pricing, not an estimate of fair value.
The essentials behind the numbers.